News Overview

Promoter/Promoter Group of Navkar Corporation Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

In terms of SEBI Circular No. SEBI/HO/CFD/CMDI/CIR/9/2019/140 dated November 21, 2019; we are enclosing herewith relevant disclosures of defaults for the quarter and year ended on March 31, 2022. You are requested to take the above submissions in your records.

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 31-Mar-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg.

Promoter/Promoter Group of Future Consumer Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Future Supply Chain Solutions Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Arvind Fashions Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Nila Spaces Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

AVRO INDIA LIMITED has informed the Exchange about press release dated 07-Apr-2022 titled AVRO India Ltd. migrates to main Board of NSE and BSE Ltd from SME Exchange

Promoter/Promoter Group of C.E. Info Systems Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Supriya Lifescience Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022